Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10015405 | 0.82 | CYP1A1 (0.39) | MEN1KMT2A | |
| SCHEMBL25005766 | 0.71 | MEN1 (0.36) | MEN1KMT2A | |
| SCHEMBL25006625 | 0.71 | MEN1 (0.36) | MEN1KMT2A | |
| SCHEMBL14700535 | 0.70 | CYP1A1 (0.38) | — | |
| SCHEMBL22652712 | 0.67 | ERN1 (0.35) | — | |
| SCHEMBL10015419 | 0.66 | MEN1 (0.35) | MEN1KMT2A | |
| SCHEMBL23349018 | 0.64 | KDM1A (0.37) | MEN1KMT2A | |
| SCHEMBL23349048 | 0.64 | KDM1A (0.37) | MEN1KMT2A | |
| SCHEMBL15859016 | 0.63 | PIK3CD (0.35) | MEN1KMT2A | |
| SCHEMBL22916738 | 0.63 | CYP11B1 (0.38) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8940413-B2 | Organic compound having acenaphtho[1,2-k]benzo[e]acephenanthrene derivative, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2015-01-27 | — | — | US | disclosed |
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | ACE, ACE2, AGTR1 | MEN1 3665/4885KMT2A 2118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.